1. Home
  2. Vol 18, No 4 (2024)
  3. Ramadhaniah

National Lung Cancer Screening: Recommended Age for Screening

Fariha Ramadhaniah, Evlina Suzanna, Elisna Syahruddin, Grace Shalmont, Pradnya Sri Rahayu

Abstract


Indonesia, as a developing country, faces a significant burden of lung cancer, with the incidence and mortality rates ranking third. Unfortunately, the majority of patients are diagnosed at advanced stages of the disease. Indonesia has implemented a national cancer control program; screening and early detection are part of this program, which needs firm criteria to restrict the high-risk population due to limited resources. This article aims to recommend age criteria for National Lung Cancer Screening based on cancer registry data. We explore lung cancer screening policies across various countries, discuss the extent of the lung cancer burden and smoking prevalence as factors in determining age criteria for screening. Lung cancer is coded using ICD-O, third edition, C33–C34, and the incidence data were obtained from the Jakarta cancer registry. Data on the prevalence of smoking were obtained from national surveys and other research. Our review suggests that lung cancer screening should start at 35 years old, considering the distribution of lung cancer, the prevalence of smoking in Indonesia, as well as the carcinogenesis process of an individual when they start smoking.

Keywords


age, lung cancer, recommendation, screening

Full Text: View | Download

DOI: 10.33371/ijoc.v18i4.1223

Article Metrics

Abstract View: 634,
PDF Download: 1068
             

References


Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.

Ramadhaniah F, Rahayu PS, Suzanna E. Berbagai Gambaran Klinis pada Kanker Paru di Rumah Sakit Kanker Dharmais ( RSKD ) Jakarta Various Clinical Features of Lung Cancer Patient in Dharmais National Cancer Hospital Jakarta. J Respir Indo. 2015;35(4):203–10.

Samiei M. Cancer control planning. Oxford Textb Oncol. 2016;245–55.

Kemenkes RI. Petunjuk Teknis Deteksi Dini Kanker Paru. Direktorat Pencegah dan Pengendali Penyakit Menular Kementeri Kesehat [Internet]. 2023; Available from: http://download.garuda.kemdikbud.go.id/article.php?article=2652619&val=24585&title=KLASIFIKASI PNEUMONIA MENGGUNAKAN METODE SUPPORT VECTOR MACHINE

The Lancet Respiratory Medicine. Feasibility of lung cancer screening in resource-poor areas. Lancet Respir Med. 2022;10(4):313.

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I BF. Indonesia Factsheet [Internet]. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2024 [cited 2024 Mar 30]. Available from: from: https://gco.iarc.who.int/today

Lukeman JM. What Is Lung Cancer? Perspect Lung Cancer. 2015;30–40.

Hong S, Won YJ, Park YR, Jung KW, Kong HJ, Lee ES. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017. Cancer Res Treat. 2020 Apr;52(2):335–50.

Horinouchi H, Kusumoto M, Yatabe Y, Aokage K, Watanabe S ichi, Ishikura S. Lung Cancer in Japan. J Thorac Oncol. 2022;17(3):353–61.

C A, Tomohiro, Carlo V di, Harewood R, Matz M, Bonaventura A. Concord-3. Lancet. 2018;391(10125):1023–75.

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010.

Holipah H, Sulistomo HW, Maharani A. Tobacco smoking and risk of all-cause mortality in Indonesia. PLoS One. 2020;15(12 December):1–12.

Badan Penelitian dan Pengembangan Kesehatan. Laporan_Nasional_RKD2018_FINAL.pdf [Internet]. Badan Penelitian dan Pengembangan Kesehatan. 2018. p. 198. Available from: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf

GATS. Gats|Global Adult Tobacco Survey Fact Sheet Indonesia 2021 Gats Objectives. Fact Sheet Indones. 2021;1–2.

Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 SUPPL):1–29.

Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, et al. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA - J Am Med Assoc. 2021;325(10):962–70.

Jang SH, Sheen S, Kim HY, Yim HW, Park BY, Kim JW, et al. The Korean guideline for lung cancer screening. J Korean Med Assoc. 2015;58(4):291–301.

Hamashima C. Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan. Jpn J Clin Oncol. 2018;48(3):278–86.

Zhou Q, Fan Y, Wang Y, Qiao Y, Wang G, Huang Y, et al. [China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2018 version)]. Zhongguo Fei Ai Za Zhi. 2018 Feb;21(2):67–75.

Shibuya K, Inoue M, Lopez AD. Statistical modeling and projections of lung cancer mortality in 4 industrialized countries. Int J Cancer. 2005;117(3):476–85.

Gao S, Li N, Wang S, Zhang F, Wei W, Li N, et al. Lung Cancer in People’s Republic of China. J Thorac Oncol. 2020;15(10):1567–76.

Biswas B, Talwar D, Meshram P, Julka PK, Mehta A, Somashekhar SP, et al. Navigating patient journey in early diagnosis of lung cancer in India. Lung India. 2023;40(1):48–58.

Nath A, Sathishkumar K, Das P, Sudarshan KL, Mathur P. A clinicoepidemiological profile of lung cancers in India – Results from the National Cancer Registry Programme. Indian J Med Res. 2022;155(2).

Lam DCL, Liam CK, Andarini S, Park S, Tan DSW, Singh N, et al. Lung Cancer Screening in Asia: An Expert Consensus Report. J Thorac Oncol. 2023;18(10):1303–22.

Andarini S, Syahruddin E, Aditya N, Zaini J, Kurniawan FD, Ermayanti S, et al. Indonesian Society of Respirology (ISR) Consensus Statement on Lung Cancer Screening and Early Detection in Indonesia. J Respirologi Indones. 2023;43(2):144–50.

Alberg AJ, Nonemaker J. Who is at high risk for lung cancer? Population-level and individual-level perspectives. Semin Respir Crit Care Med. 2008;29(3):223–32.

Hara M, Inoue M, Shimazu T, Yamamoto S, Tsugane S. The Association between cancer risk and age at onset of smoking in Japanese. J Epidemiol. 2010;20(2):128–35.

Toumazis I, Bastani M, Han SS, Plevritis SK. Risk-Based lung cancer screening: A systematic review. Lung Cancer. 2020;147(July):154–86.

Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000;355(9202):479–85.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.